GENIBET - BIOPHARMACEUTICALS SA

Country

Portugal

Type

Beneficiary

Website

www.genibet.com

Grants received

10

Funding record

• 10 grants on record
• €5,127,053.60 awarded in total
• 2008–2024 span of the record

Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.

Programmes

• Seventh Framework Programme 3 grants · €2,190,999.60
• Horizon Europe Framework Programme 2 grants · €1,600,000

5 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.

Frequent partners

Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.

• INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA 8 shared projects · 2008–2024 · Portugal
• UNIVERSIDADE NOVA DE LISBOA 4 shared projects · 2017–2024 · Portugal
• ACADEMISCH ZIEKENHUIS LEIDEN 3 shared projects · 2017–2024 · Netherlands
• EUROPEAN VACCINE INITIATIVE E.V 3 shared projects · 2017–2023 · Germany
• HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH 3 shared projects · 2017–2020 · Germany
• AFFILOGIC 2 shared projects · 2012–2015 · France
• BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE 2 shared projects · 2017–2020 · France
• CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS 2 shared projects · 2008–2012 · France

Calls from this organisation

No published calls from this organisation.

Grants received

• Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy awarded 1 October 2024 · from European Commission
• A Vaccine Targeting Eradication of Malaria €1,600,000 · awarded 1 May 2023 · from European Commission
• DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE €11,875 · awarded 1 June 2020 · from European Commission
• Vaccine for prevention and treatment of Trypanosoma cruzi infection €861,249.50 · awarded 1 June 2019 · from European Commission
• European Vaccine Research and Development Infrastructure €108,992.50 · awarded 1 May 2017 · from European Commission
• Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes €250,250 · awarded 1 March 2015 · from European Commission
• Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial €1,470,203.60 · awarded 1 January 2013 · from European Commission
• From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV €103,687 · awarded 1 November 2012 · from European Commission
• Scaffolds for alternative delivery €468,796 · awarded 1 January 2012 · from European Commission
• NONHUMAN ADENOVIRUS VECTORS FOR GENE TRANSFER TO THE BRAIN €252,000 · awarded 1 October 2008 · from European Commission